Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 3/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.45 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.34 |
| ▸ | APEX1 | P27695 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16351602 | 0.79 | POLB (0.31) | POLBTDP1CTDSP1 | |
| SCHEMBL14944739 | 0.77 | — | — | |
| SCHEMBL106105 | 0.72 | POLB (0.65) | POLBTDP1CTDSP1APEX1 | |
| SCHEMBL15645819 | 0.70 | POLB (0.62) | POLBTDP1CTDSP1APEX1 | |
| Hydrochloric Acid SCHEMBL9569081 | 0.70 | POLB (0.62) | POLBTDP1CTDSP1APEX1 | |
| SCHEMBL31453818 | 0.70 | POLB (0.50) | POLBTDP1CTDSP1APEX1 | |
| SCHEMBL2511575 | 0.70 | POLB (0.50) | POLBTDP1CTDSP1APEX1 | |
| SCHEMBL16351610 | 0.70 | POLB (0.33) | POLBTDP1APEX1 | |
| SCHEMBL16351582 | 0.70 | POLB (0.40) | POLBTDP1 | |
| SCHEMBL16351611 | 0.67 | POLB (0.38) | POLBTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150056367-A1 | COMPOSITION FOR FORMING LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY ELEMENT | SOKI CORPORATION (JP) | 2015-02-26 | — | — | US | disclosed |
| US-20140378645-A1 | LIQUID CRYSTAL ALIGNING AGENT | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2014-12-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140378645-A1 | LIQUID CRYSTAL ALIGNING AGENT | CYP17A1, AUP1, NR5A1 | POLB 846/4885TDP1 2030/4885CTDSP1 30/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.